3 November 2014: MOPEC announces the BioSeal System5 Body Bag, to help protect your facility and staff from infectious disease while transporting deceased Ebola patients. It is heat sealed for optimal protection from odors, toxins, vapors and infections.
The BioSeal System5 Body Bag is CDC approved for Level 4 Biosafety, and IATA approved for air transport. It has been field tested and certified by the US Army and Air Force, and is used by the FBI and major airlines during national disasters.
For more information call 800-362-8491, email email@example.com or click here.
29 October 2014: Leica Biosystems announces that it has entered into a definitive agreement to acquire Devicor Medical Products, Inc., a global market leader in breast biopsy instruments and consumables.
Among Devicor's products is the Original Mammotome Breast Biopsy System, which, to date, has enabled more than four million women to have a minimally invasive breast biopsy. Devicor's product portfolio also includes the Mammotome revolve, the tether-less Mammotome elite, Neoprobe Gamma Detection System, Mammotome MammoTest stereotactic biopsy table, as well as a comprehensive portfolio of tissue markers used in breast disease diagnostic sampling and management.
For more information, click here.
15 October 2014: Developed in collaboration with leading molecular genetics experts at Emory University, this highly targeted exon-focused array allows detection of medical research relevant microdeletions and microduplications. Containing over 4,600 hand-curated genes the array is an ideal complement to other genomic technologies, such as next generation sequencing (NGS), to provide accurate analysis of the full mutation spectrum.
The CytoSure Medical Research Exome array delivers:
9 October 2014: The new Tru-Q HDx™ Reference Standards range, by Horizon Diagnostics, addresses the need for routine management in Next Generation Sequencing by covering over 40 oncology-specific biomarkers at three precise allelic burdens (1.25%, 2.5% and 5%). This allows laboratories to simultaneously analyze both the sensitivity and specificity of their NGS workflows. In addition to these primary mutations, Horizon Diagnostics has characterized an additional 200 endogenous mutations in their cell lines. These mutations can be used to determine the capability and ability of a laboratory's NGS workflow to detect the full range of mutation types, including: Single Nucleotide Polymorphisms (SNPs), Untranslated Regions (UTRs), and Indels.
For more information, visit us online at www.horizondx.com.
1 October 2014: Orchard® Sequoia™ is a newly developed enterprise-class LIS that employs the latest in human computer interaction (HCI) design as well as a cutting edge modular platform framework. This new LIS is instinctively easy-to-use and designed to be scalable to accommodate large volumes of laboratory testing across multiple laboratories and departments performing clinical, microbiology, molecular, and pathology testing.
1 October 2014: Yale University West Campus announces a new microscopy Center of Excellence made possible through a partnership with Leica Microsystems. Housed in a newly created core facility, the Leica Center of Excellence at Yale West Campus will provide scientists with access to cutting-edge imaging tools to resolve sub-cellular structures and forward scientific discoveries. This relationship will afford researchers access to expert technical and applications support, along with instrumentation which Leica Microsystems will continuously update with the latest technology. In addition, Yale and Leica Microsystems will collaborate in the development of novel imaging technologies.
Scientists are invited to take part in the Opening Ceremonies on October 20-21, 2014, featuring scientific, applications and technology talks, round table discussions and a keynote address from Joerg Bewersdorf Ph.D., Associate Professor of Cell Biology and of Biomedical Engineering at the Yale School of Medicine. Then, through October 31, 2014, Leica Microsystems will be hosting a super-resolution workshop with free access and sample preparation guidance using GSDIM and STED technologies. On campus, Yale University scientists also are invited for preparatory morning seminars on sample preparation October 7 to 8, 2014. Interested parties can register here.
15 September 2014: Biocare Medical, LLC, is the exclusive distributor of the ERG [9FY] mouse monoclonal antibody for in vitro diagnostics by immunohistochemistry staining and for research purposes, which was recently patented by The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. in the United States (Patent No: US 8,765,916 B2) and Europe. ERG [9FY] may have diagnostic utility for prostate cancer, acute myeloid leukemia and vascular tumors. 9FY can accurately discriminate between ERG positive prostate cancer cells and lymphocytes and other cell types, helping to establish prostatic origin in metastatic carcinomas. ERG may also be used to diagnose tumors of endothelial origin, such as angiosarcoma, variants of hemangioma, Kaposi sarcoma, and staging AML lymphoid tumors, as 9FY stains blood and lymphatic endothelial cells.
Please click here for more information.
5 September 2014: Understanding that accurate control of all pre-analytical steps is essential for precise, reliable, and consistent diagnostic assays, Milestone introduces the FixSTATION family of standardization products for the modern Pathology lab.
The FixSTATION JS, 1R, 2R, 3R, and 3RH, ranging from basic to advance models, are designed to optimize and document the patient specimen fixation step. Agitation, temperature control, laboratory grade materials, clear user interface design, multiple concurrent cassette rack runs, and report generation are a few of the features.
Take control of your fixation variables, learn the complete FixSTATION story by calling 866-995-5300, emailing firstname.lastname@example.org, or visiting www.milestonemed.com.
30 June 2014: Milestone introduces SealSAFE, a system for eliminating formalin exposure and standardizing fixative volumes during specimen management and transport.
SealSAFE enables Surgical and Laboratory professionals to safely manage and tranfer patient specimens from the OR to Pathology using laboratory grade vacuum bags. Specimen bags are placed into a sealing chamber, automatically weighed, then a preselected ratio of fixative is added prior to vacuum completion. The fully vented unit extracts formalin fumes from the reagent drawer and sealing chamber, keeping users safe.
Benefits include reduced exposure to harmful fumes, lower fixative use through more efficient ratios, documentation of fixation start time, barcode identification of specimens, and cost reductions in waste disposal of archived case tissue.
Learn the complete SealSAFE story by calling 866-995-5300, emailing email@example.com
or visiting www.milestonemed.com.
17 June 2014: To improve consistency and completeness in reporting results of cancer biomarker testing, the College of American Pathologists (CAP) has produced the Template for Reporting Results of HER2 (ERBB2) Biomarker Testing of Specimens from Patients With Adenocarcinoma of the Stomach or Esophagogastric Junction. This template was developed to respond to pathologist user feedback about timing of reporting and structural consistency of ancillary studies data elements in the CAP Cancer Protocols and to provide educational materials to help pathologists better understand emerging biomarkers. The development of these templates has been a collaborative effort between the CAP, AMP, ASCO, CDC, AJCC, and many other participating organizations.
The CAP Cancer Protocols are available on the CAP website, by clicking cap.org/CancerProtocols.
9 June 2014: Voicebrook, Inc. announces the release of its latest VoiceOver® module providing Structured Results Entry (SRE) for cancer reporting. VoiceOver® SRE helps pathologists comply with the College of American Pathologists (CAP) reporting guidelines for primary cancer cases.
Voicebrook has created a module fully supported by speech recognition, which imports the CAP eCC files and make them available to our customers through a user-friendly and efficient front-end interface. The VoiceOver® solution also integrates Dragon® Medical 360 speech recognition technology from Nuance Communications.
For more information on Voicebrook, please visit http://www.voicebrook.com.
25 February 2014: Photodyne Technologies is pleased to offer their new line of grossing macrophotography units. The P series units are available with off the shelf Point and Shoot cameras or with top of the line DSLR cameras with 18 MP resolution allowing RAW data manipulation. These new units incorporate low DC voltage operation for enhanced safety and with all LED bulbs for cool and more efficient performance. Model 701-P is a full size console and model 702-P is a desk top model, both with 30 by 20 photographing area. Model 703-P is a smaller footprint unit with 20 by 13 photographing surface area. Prices for the new units start at $6725 for model 701-P, $5975 for model 702-P, and $5575 for model 703-P.
For more information, visit us online at www.photodyne.com, or contact us at 800-660-2147 or firstname.lastname@example.org.
21 February 2014: Mopec introduces the FD500, our Formalin Dispensing Station. Constructed of all stainless steel, it features a 7.5" W x 9" deep sink. Three grid plates are provided (one sink and two perforated). Additional standard features include: GFCI, fluorescent lighting, high low alarm lights, adjustable shelf, bi-parting lexan doors, lexan side splash shield and leveling pads.
For more information call 800-362-8491, email email@example.com or visit www.MOPEC.com.
26 August 2013: PerkinElmer and Advanced Cell Diagnostics (ACD) have entered a co-marketing agreement to develop joint applications for the visualization of multiplexed fluorescence RNA biomarkers in situ, in formalin-fixed paraffin-embedded tissues. In the past, it was not possible to detect and quantify RNA in situ in these samples due to lack of sensitivity and specificity of labels within highly autofluorescent tissues.
Click here for more information.
12 June 2013: HANSEL Stain has been the recommended in-vitro diagnostic stain for the identification of eosinophils in secretions for many years. Please see our product summary on Pathology Outlines here.
Lide Laboratories also offers other diagnostics stains including our new Urine Sediment Stain and Tinea Test Stain. Our concentrated Urine Sediment Stain combines Crystal Violet (0.1%), Ammonium Oxalate (0.03%) and Safranin O (0.25%) with the base formula used in HANSEL Stain. Our Tinea Test Stain [Lactophenol Cotton (Aniline) Blue (0.05%)] is formulated for the microscopic examination of fungi.
Please see our web page for more information: www.lidelabs.com/diagnosticstains.html. New customers can send us a request for free samples on our Contact Us web page.
14 April 2013: PSA is pleased to announce that we are now part of McKesson. This combined organization brings together an extensive portfolio of services and we are now better positioned to help our customers choose from a broader set of services from practice and revenue cycle management to coding, marketing and networking capabilities.
To learn more, visit www.McKesson.com/pathologyservices, or contact Leigh Polk at Leigh.Polk@McKesson.com.
13 October 2012: Introducing EXAKTÃ¢â‚¬â„¢s NEW Pathology Saw. Designed specifically for pathology lab use, this bone saw offers the SAFEST alternative for grossing samples. Unlike butcher saws used in many labs, the diamond band of the EXAKT saw does not cut, but grinds the bone very precisely. There is no immediate risk of injury to the technician if the band is touched unintentionally. The EXAKT 312 Diamond Pathology Saw easily cuts metal implants or screws encountered during the grossing process, without destroying the sample. Even very small specimens can be cut safely and precisely! Visit www.exaktusa.com/pathology-saw and watch the EXAKT Pathology Saw Video.
26 July 2011: OPTRONICS presents a case study about High Definition Hematology. In 2009, the Royal Berkshire Hospital (RBH) made the decision to update its microscope camera system. Located in the Haematology Department, the equipment originally consisted of a microscope mounted analogue video camera connected to a 21-inch professional monitor. This was used for presentations and training purposes for over ten years until it started to fail and display picture defects. Click
here to read the short article.
For more information, contact Rich Crandall, Director of Business Development at 805.562.3980 or firstname.lastname@example.org, or visit us online at http://www.optronics.com.
26 January 2011: ARUPÃ¢â‚¬â„¢s Online Scientific Resource for Research and Education provides more than 20 free CME courses for physicians. Course topics reflect current issues and developments in pathology; new courses are added monthly. This resource is provided by ARUPÃ¢â‚¬â„¢s medical directors, who are faculty at the University of Utah School of Medicine, along with other highly qualified expert contributors.
The University of Utah School of Medicine designates these educational activities for AMA PRA Category 1 credit(s) and affirms that they meet the criteria for Self-Assessment Modules (SAM) credit to apply toward the Maintenance of Certification (MOC) by the American Board of Pathology.
For more information, click here.
10 February 2009: Vachette Pathology is proud to announce its newly improved website Vachettepathology.com. The website will have more content and more information. The goal of the website will be to concentrate all the knowledge and experience we have into a single database that is more useable for both our current and potential customers.
Vachette Pathology is a practice management firm that specializes in pathology. Currently we work with over 450 pathologists nationwide and are commonly held as the industry leaders in the business of pathology and laboratory management.
If you have any questions or for further information, please contact Mick Raich toll free at 866-407-0763, or email email@example.com